Portfolio  BioGeneration Ventures II

 

Acerta Pharma www.acerta-pharma.com

Location Oss (The Netherlands)
Fund BioGeneration Ventures II B.V.
Year 2013
Status Realized
Acerta Pharma develops novel therapeutics in oncology and autoimmune diseases.

Cristal Therapeutics www.cristaltherapeutics.com

Location Maastricht (The Netherlands)
Fund BioGeneration Ventures II B.V.
Year 2012
Status Active
Cristal Therapeutics develops a new class of nanomedicines based on its proprietary polymeric technologies with an optimized drug disposition and a more favorable tolerability profile.

Dezima Pharma 

Location Amsterdam (The Netherlands)
Fund BioGeneration Ventures II B.V.
Year 2012
Status Realized
Dezima Pharma develops a best in class CETP inibitor for the treatment of cardiovascular disease.

SurgVision  www.surgvision.com

Location 't Harde (The Netherlands)
Fund BioGeneration Ventures II B.V.
Year 2013
Status Active
SurgVision develops fluoresence imaging systems including tracers for use in image guided surgery, e.g., in breastcancer.

Synaffix  www.synaffix.com

Location Oss (The Netherlands)
Fund BioGeneration Ventures II B.V.
Year 2013
Status Active
Synaffix develops a next generation ADC platform.
 

‚Äč

 

 

Desktop versie